Dr. Kira Sheinerman (Bronfman parent ’17) is the co-founder and CEO of DiamiR, a life sciences company developing blood-based diagnostic solutions for brain health diseases. She is also a Managing Director, Investment Banking at H.C. Wainwright & Co. where she works on financial and strategic transactions for growth biotech companies. Kira serves on the Board of Directors of the Boyce Thompson Institute, an affiliate of Cornell University, and as the senior strategic consultant to Aptorum Group (NASDAQ: APM). From October 2015 through December 2018, Kira served as the co-chair of Alzheimer’s Association Business Consortium. Kira received her Ph.D. in Biomedical Sciences from Mount Sinai School of Medicine for her work on molecular mechanisms of Alzheimer’s disease. She also holds an Honors MBA from the Zicklin School of Business, Baruch College/CUNY. Kira lives in NYC with her husband and two daughters.
